查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1985734

生物檢體處理市場：全球市場預測（按產品類型、工作流程、檢體類型、應用和最終用戶分類），2026-2032年

Biological Sample Handling Market by Product Type, Workflow, Sample Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，生物樣本處理市場價值將達到 210.9 億美元，到 2026 年將成長至 224.2 億美元，到 2032 年將達到 331.6 億美元，複合年成長率為 6.67%。

主要市場統計數據
基準年 2025 210.9億美元
預計年份：2026年 224.2億美元
預測年份 2032 331.6億美元
複合年成長率 (%) 6.67%

透過明確營運重點、品質壓力以及跨職能決策的必要性，我們為生物檢體處理建立了策略背景。

現代生物檢體處理體系處於科學嚴謹性、營運效率和嚴格法律規範三者交會的十字路口。實驗室、臨床機構、研究中心和工業研發團隊面臨著從樣本採集到檢體全程維護檢體完整性的日益成長的要求。儘管自動化、數位化和試劑化學的進步正在改變日常工作流程，但對可重複性和可追溯性的不斷提高的期望要求更嚴格的流程控制和檢驗的供應鏈。

整體情況了將透過自動化、試劑創新和數據驅動的儲存歷史管理解決方案重塑檢體處理的變革性變化。

生物檢體處理領域正經歷一場變革，其驅動力包括技術的成熟、監管機構對資料完整性的重視，以及臨床和科學研究終端使用者不斷變化的需求。自動化正從單一儀器發展到整合的工作流程平台，這些平台整合了樣本採集、處理和儲存功能，使實驗室能夠在擴大處理能力的同時減少人為錯誤。試劑配方和試劑盒設計的同步進步提高了不同檢測方法之間的穩定性和相容性，從而降低了變異性並縮短了驗證週期。

評估 2025 年推出的關稅措施對檢查室採購、供應商策略和供應鏈韌性的累積營運和採購影響。

2025年實施的新關稅措施增加了全球生物檢體處理供應鏈的複雜性，影響了籌資策略和營運規劃。進口檢測設備、耗材和某些試劑類別的關稅調整增加了依賴跨境採購的機構的接收成本，迫使採購團隊重新評估供應商選擇和庫存策略。為此，許多機構正在重新計算其總擁有成本（TCO），以反映關稅、更長的前置作業時間和增加的物流風險。

透過整合產品、最終用戶、應用、檢體類型和工作流程因素來確定採購和驗證的優先事項，我們提供可操作的細分見解。

對市場區隔的詳細分析揭示了產品類型、最終用戶、應用、樣本類型和工作流程如何影響整個樣本處理過程中的採購優先順序和創新應用。對產品類型的檢驗表明，耗材、儀器、試劑/試劑盒和軟體/服務各自為買家提供不同的價值提案。在儀器領域，由於實驗室尋求更高的處理能力和可重複性，對自動移液系統、溫控離心機和渦旋混合器的需求尤其強勁。同時，抗體、緩衝液/溶液、酵素和標記/檢測試劑等試劑和試劑盒對檢測性能和相容性有顯著影響。最終用戶的多樣性影響著採購行為。學術和研究機構、生物製藥公司、受託研究機構(CRO)、診斷檢查室和醫院在驗證、處理能力和成本控制方面採用不同的標準。特別是診斷檢查室，又細分為臨床化學、血液學、微生物學和分子診斷，每個實驗室都有其獨特的處理要求。

本文說明了區域管理體制、製造能力和物流基礎設施如何為美洲、歐洲、中東和非洲以及亞太地區創造不同的機會。

隨著各組織評估區域法規結構、製造地和物流基礎設施，區域趨勢正在影響檢體處理的策略選擇。在美洲，需求模式反映了高通量臨床檢查室中心和生物製藥研發機構的廣泛需求，這些機構優先考慮自動化、長期供應商關係以及快速獲取新型試劑。供應鏈整合和主要合約服務供應商的存在進一步影響供應商的選擇和首選的經營模式。

在預處理階段，透過結合檢驗的產品系列、服務模式和互通性，識別供應商之間的競爭差異化因素，以減少變異性。

在檢體處理生態系統中，競爭格局日益取決於企業提供涵蓋硬體、耗材、試劑和資訊服務的一體化提案主張的能力。擁有完善的品質系統、法規支援和清晰檢驗文件的供應商通常更受受監管的終端用戶青睞。同時，擁有模組化和互通平台的供應商則更受高通量研究機構和工業客戶的青睞。投資於特定應用試劑盒和試劑以及檢驗的通訊協定的企業，能夠降低採用門檻並提高客戶維繫，尤其是在診斷流程和受監管的藥物開發工作流程中。

為領導者提供切實可行的建議，以加強供應鏈韌性、規範驗證並擴大自動化，從而降低預分析和營運風險。

產業領導者可立即採取行動，透過協調籌資策略、合格計畫和跨職能管治來提升檢體處理效率。首先，應建立嚴格的供應商資格認證流程，評估批次間一致性文件、試劑穩定性數據和耗材可追溯性，並在合約中明確關稅和物流風險。其次，應優先投資自動化系統，以顯著減少人為錯誤並實現穩定的處理能力。同時，應實施培訓計劃，確保檢查室人員能夠有效操作和維護自動化系統。

為了確保實用和準確的見解，我們描述了一種嚴格的混合方法調查方法，該方法結合了初步訪談、技術文獻綜述和專家檢驗。

本研究途徑結合了結構化的初步調查和有針對性的二次分析，旨在對生物檢體處理動態進行穩健且基於證據的評估。初步數據包括對實驗室經理、採購經理、品質保證負責人和供應鏈經理的訪談，以收集關於挑戰、推廣促進因素和檢驗障礙的第一手觀點。這些訪談旨在了解操作細節，例如工作流程瓶頸、試劑穩定性問題和儀器運轉率優先級，並確保匿名性和保密性，以鼓勵受訪者坦誠作答。

最後，我們將清楚地總結如何透過對自動化、經驗證的試劑和穩健的採購進行協調投資來確保檢體完整性和營運連續性。

總而言之，生物檢體處理產業正處於轉折點，技術創新、監管和供應鏈趨勢在此交匯，重新定義了檢查室保護檢體完整性和加速發現的方式。積極投資於可互通自動化系統、經過驗證的試劑系統和即時監管鏈監控的機構，將更有能力管理分析前變異性和履行合規義務。同樣重要的是，鑑於關稅壓力和物流不確定性，對採購慣例進行策略性重新評估，這將有助於供應商組合多元化和加強區域夥伴關係關係。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 生物檢體處理市場：依產品類型分類

  • 消耗品
  • 裝置
    • 自動移液系統
    • 溫控離心分離器
    • 渦流混合器
  • 試劑和試劑盒
    • 抗體
    • 緩衝液和溶液
    • 酵素
    • 標記和檢測試劑
  • 軟體和服務

第9章 生物檢體處理市場：依工作流程分類

  • 分析
  • 收藏
  • 預處理
  • 貯存
  • 運輸

第10章：檢體類型分類的生物檢體處理市場

  • 血
  • 細胞
  • 組織
  • 尿

第11章：生物檢體處理市場：依應用領域分類

  • 診斷
    • 臨床檢測
    • 照護端
  • 藥物發現與開發
  • 基因組學
  • 蛋白質體學

第12章 生物檢體處理市場：依最終用戶分類

  • 學術研究機構
  • 生物製藥公司
  • 合約研究機構
  • 診斷檢查室
    • 臨床化學
    • 血液學
    • 微生物學
    • 分子診斷
  • 醫院

第13章 生物檢體處理市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：生物檢體處理市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 生物檢體處理市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國生物檢體處理市場

第17章：中國生物檢體加工市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Accelerated Laboratory Logistics
  • Alliance Pharma PLC
  • Azenta Life Sciences
  • BioDock Limited
  • BioLife Solutions Inc.
  • Clinigen Group
  • Cryoniss
  • Cryoport Systems, LLC
  • Discovery Life Sciences
  • Eppendorf SE
  • Hamilton Company
  • Infiuss Health
  • Labtoo
  • Marken by United Parcel Service, Inc.
  • Mercury Business Services
  • MLM Medical Labs
  • Oximio
  • PrecisionMed, LLC
  • ReproCELL Inc.
  • SAROUTE Co., Ltd.
  • SPT Labtech Ltd.
  • Thermo Fisher Scientific Inc.
  • Ziath Ltd.
Product Code: MRR-757B1C9CB0B6

The Biological Sample Handling Market was valued at USD 21.09 billion in 2025 and is projected to grow to USD 22.42 billion in 2026, with a CAGR of 6.67%, reaching USD 33.16 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 21.09 billion
Estimated Year [2026] USD 22.42 billion
Forecast Year [2032] USD 33.16 billion
CAGR (%) 6.67%

Establishing the strategic context for biological sample handling by outlining operational priorities, quality pressures, and cross-functional decision imperatives

The contemporary ecosystem for biological sample handling sits at the intersection of scientific rigor, operational efficiency, and stringent regulatory oversight. Laboratories, clinical facilities, research centers, and industrial R&D teams face an expanding set of requirements to preserve sample integrity from collection through analysis. Advances in automation, digitization, and reagent chemistry are reshaping daily workflows, while heightened expectations around reproducibility and traceability demand tighter process controls and validated supply chains.

Against this backdrop, organizations must balance cost pressures with the imperative to minimize pre-analytical variability. Investments in instrumentation, consumables, and end-to-end workflow solutions increasingly reflect a strategic choice to reduce downstream assay failures and accelerate time to insight. As practices evolve, cross-functional collaboration among procurement, laboratory operations, quality, and informatics becomes vital to ensure that equipment selection, reagent sourcing, and storage protocols collectively support scientific objectives without introducing unmanageable complexity. This introduction frames the primary forces influencing decision-making and sets the stage for deeper analysis of technological shifts, policy impacts, and segmentation-specific dynamics that follow.

Mapping the transformative shifts reshaping sample handling through automation, reagent innovation, and data-driven chain-of-custody solutions

The landscape of biological sample handling is undergoing transformative shifts driven by technological maturation, regulatory emphasis on data integrity, and changing demand patterns from both clinical and research end users. Automation is moving beyond isolated instruments to integrated workflow platforms that combine collection, processing, and storage functions, enabling labs to scale throughput while reducing human error. Parallel advances in reagent formulations and kit design are improving stability and compatibility across diverse assay modalities, which in turn reduces variability and shortens validation timelines.

Data-centric approaches are becoming central; laboratory informatics systems and connected devices now enable real-time monitoring of sample chain-of-custody and environmental conditions. This connectivity supports risk-based quality management and allows organizations to detect and remediate deviations more quickly. Additionally, there is an increasing premium on modular solutions that can be configured to meet both high-throughput industrial needs and smaller, decentralized clinical settings. Taken together, these trends are reshaping procurement priorities, incentivizing scalable investments, and redefining the vendor landscape as suppliers compete to offer interoperable, validated systems that span multiple steps of the sample lifecycle.

Assessing the cumulative operational and sourcing impacts of tariff measures introduced in 2025 on laboratory procurement, supplier strategies, and supply chain resilience

The advent of new tariff measures in 2025 has introduced a layer of complexity to global supply chains that support biological sample handling, affecting procurement strategies and operational planning. Tariff adjustments on imported laboratory equipment, consumables, and certain reagent categories have increased landed costs for organizations that rely on cross-border sourcing, prompting procurement teams to re-evaluate supplier selection and inventory policies. In response, many organizations are revisiting total cost of ownership calculations to reflect duties, longer lead times, and elevated logistics risk.

Consequently, buyers are exploring alternatives such as nearshoring, supplier diversification, and longer-term contracts to mitigate exposure to tariff volatility. These approaches generally emphasize building relationships with regional manufacturers and distributors, qualifying secondary suppliers to maintain continuity, and increasing buffer inventories for critical items. Regulatory-driven requirements for validated supply chains and traceability further complicate substitution decisions, creating tension between cost mitigation and compliance. Overall, the cumulative impact of the tariffs is accelerating strategic shifts toward more resilient sourcing models, greater supply chain transparency, and heightened collaboration between procurement and laboratory operations to balance affordability with uninterrupted access to validated materials and equipment.

Delivering practical segmentation insights by synthesizing product, end user, application, sample type, and workflow drivers that determine procurement and validation priorities

A nuanced view of segmentation reveals how product type, end user, application, sample type, and workflow each shape procurement priorities and innovation adoption across the sample handling continuum. Examining product type shows that consumables, instruments, reagents and kits, and software and services occupy distinct value propositions to buyers; within instruments there is a pronounced demand for automated pipetting systems, temperature-controlled centrifuges, and vortex mixers as laboratories seek throughput gains and reproducibility, while reagents and kits such as antibodies, buffers and solutions, enzymes, and labeling and detection reagents drive assay performance and compatibility. End user diversity affects purchasing behavior, as academic and research institutes, biopharmaceutical companies, contract research organizations, diagnostic laboratories, and hospitals each apply different standards for validation, throughput, and cost control, and diagnostic laboratories in particular subdivide into clinical chemistry, hematology, microbiology, and molecular diagnostics, each with its own handling requirements.

Application-level distinctions between diagnostics, drug discovery and development, genomics, and proteomics direct investments toward tailored solutions; diagnostics further differentiates along laboratory diagnostics and point-of-care pathways, where portability and stability become pivotal. Sample type considerations, encompassing blood, cells, tissue, and urine, impose varying constraints on collection devices, preservatives, storage temperatures, and transport logistics. Finally, the workflow segmentation across analysis, collection, processing, storage, and transport underscores the need for interoperable solutions that preserve pre-analytical integrity. These overlapping segmentations demonstrate that decisions about product selection and process design must be made in the context of specific end-use cases and operational constraints to achieve both scientific rigor and economic efficiency.

Explaining how regional regulatory regimes, manufacturing capacity, and logistical infrastructure create differentiated opportunities across the Americas, EMEA, and Asia-Pacific

Regional dynamics are shaping strategic choices in sample handling as organizations weigh local regulatory frameworks, manufacturing footprints, and logistical infrastructure. In the Americas, demand patterns reflect a broad mix of high-throughput clinical laboratories, translational research centers, and biopharmaceutical R&D hubs that prioritize automation, long-term supplier relationships, and rapid access to novel reagents. Supply chain integration and the presence of large contract service providers further influence vendor selection and preferred commercial models.

Across Europe, Middle East & Africa, the landscape is heterogeneous: robust regulatory regimes and centralized healthcare systems in several European markets drive strong emphasis on compliance and validated cold chain capabilities, while emerging markets within the region often focus on affordability, reagent stability at ambient temperatures, and solutions that enable decentralized testing. In Asia-Pacific, rapid investment in genomic and proteomic research, coupled with growing domestic manufacturing capacity, is accelerating adoption of both high-end instruments and localized consumable production. Collectively, these regional differences underscore the importance of tailoring go-to-market strategies, regulatory engagement, and supply chain architecture to local conditions rather than pursuing a uniform global approach.

Identifying competitive differentiators among suppliers that combine validated product portfolios, service models, and interoperability to reduce pre-analytical variability

Competitive dynamics in the sample handling ecosystem are increasingly defined by the ability of organizations to offer integrated value propositions that span hardware, consumables, reagents, and data services. Suppliers that combine robust quality systems, regulatory support, and clear documentation for validation typically gain preference among regulated end users, while those with modular, interoperable platforms appeal to high-throughput research and industrial customers. Companies that invest in application-specific kits and reagents, along with validated protocols, reduce adoption friction and improve customer retention, particularly in diagnostic pathways and regulated drug development workflows.

Service-oriented business models, including instrument-as-a-service, reagent subscription programs, and remote monitoring, are emerging as differentiators that lower upfront capital barriers and provide predictable operational expenditure profiles. Strategic partnerships between instrument manufacturers and reagent suppliers, as well as collaborations with informatics vendors, are enabling more complete solutions that address pre-analytical variability. For procurement leaders, preferred suppliers are those that combine technical reliability, transparent quality practices, and agility in adapting to localized compliance requirements and logistical constraints.

Actionable recommendations for leaders to strengthen supply resilience, standardize validation, and scale automation to reduce pre-analytical risk and operational exposure

Industry leaders can take immediate, actionable steps to fortify sample handling operations by aligning procurement strategy, validation planning, and cross-functional governance. First, embed rigorous supplier qualification processes that evaluate documentation for lot-to-lot consistency, stability data for reagents, and traceability for consumables, while ensuring that contracts address tariff and logistics risks. Second, prioritize investments in automation where it demonstrably reduces manual error and enables consistent throughput; pair these investments with training programs that equip laboratory staff to operate and maintain automated systems effectively.

Third, adopt a risk-based approach to inventory and sourcing that blends regional supplier diversification with strategic onshore or nearshore partnerships to mitigate tariff exposure and lead time variability. Fourth, integrate environmental and chain-of-custody monitoring into laboratory informatics to provide real-time visibility into storage and transport conditions, supporting faster corrective actions and audit readiness. Finally, cultivate cross-functional steering committees composed of procurement, quality, laboratory operations, and R&D to oversee validation protocols, change controls, and supplier performance metrics. These measures collectively improve sample integrity, reduce operational disruptions, and create clearer pathways for scaling scientific operations responsibly.

Explaining a rigorous mixed-methods research methodology that integrates primary interviews, technical literature review, and expert validation to ensure actionable and accurate findings

The research approach combines structured primary engagement with targeted secondary analysis to produce a robust, evidence-based assessment of biological sample handling dynamics. Primary inputs include interviews with laboratory directors, procurement leads, quality assurance professionals, and supply chain managers to capture firsthand perspectives on pain points, adoption drivers, and validation hurdles. These conversations are framed to elicit operational details such as workflow bottlenecks, reagent stability concerns, and instrumentation uptime priorities while ensuring anonymity and confidentiality to promote candid responses.

Secondary research involves systematic review of technical literature, regulatory guidance, product documentation, and case studies to triangulate findings and test hypothesis robustness. Data synthesis emphasizes cross-validation across sources and stress-tests scenario assumptions to identify risks and opportunity levers. Where applicable, expert panels composed of experienced laboratorians and industry technologists review drafts to ensure practical relevance and technical accuracy. Finally, the methodology applies rigorous quality checks for internal consistency, logical coherence, and alignment with the latest published standards to ensure that conclusions are actionable and reflective of current operational realities.

Concluding with a clear synthesis of how coordinated investments in automation, validated reagents, and resilient sourcing secure sample integrity and operational continuity

In summary, the biological sample handling domain is at an inflection point where technological innovation, regulatory scrutiny, and supply chain dynamics converge to redefine how laboratories protect sample integrity and accelerate discovery. Organizations that proactively invest in interoperable automation, validated reagent systems, and real-time chain-of-custody monitoring will be better positioned to manage pre-analytical variability and compliance obligations. Equally important is the strategic reorientation of sourcing practices in light of tariff pressures and logistics uncertainties, which favors diversified supplier portfolios and stronger regional partnerships.

Taken together, these developments imply that operational excellence in sample handling is achieved not by isolated purchases but by coordinated programs that align procurement, quality, and laboratory operations around shared performance metrics. Leadership that fosters cross-functional governance, invests in staff capability, and prioritizes modular, validated solutions will capture the dual benefits of scientific reproducibility and operational resilience. The conclusion underscores the urgency for stakeholders to translate these insights into prioritized actions that protect scientific output and sustain organizational momentum.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Biological Sample Handling Market, by Product Type

  • 8.1. Consumables
  • 8.2. Instruments
    • 8.2.1. Automated Pipetting Systems
    • 8.2.2. Temperature Controlled Centrifuges
    • 8.2.3. Vortex Mixers
  • 8.3. Reagents And Kits
    • 8.3.1. Antibodies
    • 8.3.2. Buffers And Solutions
    • 8.3.3. Enzymes
    • 8.3.4. Labeling And Detection Reagents
  • 8.4. Software And Services

9. Biological Sample Handling Market, by Workflow

  • 9.1. Analysis
  • 9.2. Collection
  • 9.3. Processing
  • 9.4. Storage
  • 9.5. Transport

10. Biological Sample Handling Market, by Sample Type

  • 10.1. Blood
  • 10.2. Cells
  • 10.3. Tissue
  • 10.4. Urine

11. Biological Sample Handling Market, by Application

  • 11.1. Diagnostics
    • 11.1.1. Laboratory Diagnostics
    • 11.1.2. Point Of Care
  • 11.2. Drug Discovery And Development
  • 11.3. Genomics
  • 11.4. Proteomics

12. Biological Sample Handling Market, by End User

  • 12.1. Academic And Research Institutes
  • 12.2. Biopharmaceutical Companies
  • 12.3. Contract Research Organizations
  • 12.4. Diagnostic Laboratories
    • 12.4.1. Clinical Chemistry
    • 12.4.2. Hematology
    • 12.4.3. Microbiology
    • 12.4.4. Molecular Diagnostics
  • 12.5. Hospitals

13. Biological Sample Handling Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Biological Sample Handling Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Biological Sample Handling Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Biological Sample Handling Market

17. China Biological Sample Handling Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Accelerated Laboratory Logistics
  • 18.6. Alliance Pharma PLC
  • 18.7. Azenta Life Sciences
  • 18.8. BioDock Limited
  • 18.9. BioLife Solutions Inc.
  • 18.10. Clinigen Group
  • 18.11. Cryoniss
  • 18.12. Cryoport Systems, LLC
  • 18.13. Discovery Life Sciences
  • 18.14. Eppendorf SE
  • 18.15. Hamilton Company
  • 18.16. Infiuss Health
  • 18.17. Labtoo
  • 18.18. Marken by United Parcel Service, Inc.
  • 18.19. Mercury Business Services
  • 18.20. MLM Medical Labs
  • 18.21. Oximio
  • 18.22. PrecisionMed, LLC
  • 18.23. ReproCELL Inc.
  • 18.24. SAROUTE Co., Ltd.
  • 18.25. SPT Labtech Ltd.
  • 18.26. Thermo Fisher Scientific Inc.
  • 18.27. Ziath Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY AUTOMATED PIPETTING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY AUTOMATED PIPETTING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY AUTOMATED PIPETTING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TEMPERATURE CONTROLLED CENTRIFUGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TEMPERATURE CONTROLLED CENTRIFUGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TEMPERATURE CONTROLLED CENTRIFUGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY VORTEX MIXERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY VORTEX MIXERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY VORTEX MIXERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ANTIBODIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ANTIBODIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BUFFERS AND SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BUFFERS AND SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BUFFERS AND SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ENZYMES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY LABELING AND DETECTION REAGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY LABELING AND DETECTION REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY LABELING AND DETECTION REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SOFTWARE AND SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SOFTWARE AND SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COLLECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COLLECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COLLECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PROCESSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TRANSPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TRANSPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TRANSPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BLOOD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BLOOD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CELLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CELLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TISSUE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TISSUE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY URINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY URINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY URINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY LABORATORY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY LABORATORY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY LABORATORY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY POINT OF CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY POINT OF CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY GENOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY GENOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY GENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PROTEOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PROTEOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CLINICAL CHEMISTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CLINICAL CHEMISTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY MICROBIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY MICROBIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 208. GCC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 209. GCC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. GCC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 211. GCC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 212. GCC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 213. GCC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. GCC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. GCC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 216. GCC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. GCC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 238. G7 BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 239. G7 BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. G7 BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 241. G7 BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 242. G7 BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 243. G7 BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. G7 BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 245. G7 BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 246. G7 BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 247. G7 BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 248. NATO BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 249. NATO BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. NATO BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 251. NATO BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 252. NATO BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 253. NATO BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. NATO BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 255. NATO BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 256. NATO BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 257. NATO BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 258. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 269. CHINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 270. CHINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 272. CHINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 273. CHINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 274. CHINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. CHINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 276. CHINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 278. CHINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)